The European market for vascular access devices will see slight growth over the forecast period, driven in large part by the rising adoption of PICCs in all European countries, as well as the rising adoption of new technologies such as power-injectable devices, and devices with antimicrobial coatings. However, market revenues will be hindered to some extent by declining ASPs resulting from pricing pressures and increasing competition. Overall, rising unit sales—predominantly due to an aging population—and the uptake of premium-priced products will spur revenue growth in the European vascular access device market.
This Medtech 360 Report provides high-level market metrics for the vascular access device market in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
- Vascular Access Devices - Market Insights - Europe (Supplemental)
Author(s): Bishwjit Ghoshal, MBA
Bishwjit Ghoshal is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.
Follow Bishwjit on twitter: @Bishwjit_DRG